NCT02259179 - Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Healthy

Interventions

DRUG

Reference naltrexone 8 mg SR/bupropion 90 mg SR combination trilayer tablets (2 tablets)

DRUG

Test naltrexone 8 mg SR/bupropion 90 mg SR combination trilayer tablets (2 tablets)

Trial Locations (1)

Quintiles Phase One Services, LLC, Overland Park